These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15363560)

  • 1. Lymphadenectomy with cystectomy: is it necessary and what is its extent?
    Ghoneim MA; Abol-Enein H
    Eur Urol; 2004 Oct; 46(4):457-61. PubMed ID: 15363560
    [No Abstract]   [Full Text] [Related]  

  • 2. Separating surgical quality from causality--gaining perspective in the debate on lymph node count and extent of lymphadenectomy.
    Gilbert SM
    Cancer; 2008 Jun; 112(11):2331-3. PubMed ID: 18383514
    [No Abstract]   [Full Text] [Related]  

  • 3. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment.
    Olsson CA
    Urology; 2009 Jul; 74(1):166. PubMed ID: 19567299
    [No Abstract]   [Full Text] [Related]  

  • 5. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of lymphadenectomy for muscle invasive transitional cell carcinoma of the human bladder - a review of the literature].
    Alloussi SH; Huber S; Gakis G; Stenzl A; Schwentner C
    Aktuelle Urol; 2011 Mar; 42(2):115-21. PubMed ID: 21437835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial comment.
    Herr HW
    Urology; 2009 Jul; 74(1):166. PubMed ID: 19567298
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of radical cystectomy.
    Thalmann GN; Stein JP
    BJU Int; 2008 Nov; 102(9 Pt B):1279-88. PubMed ID: 19035893
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of lymphadenectomy in high-grade invasive bladder cancer.
    Stein JP; Skinner DG
    Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients.
    Canter D; Guzzo TJ; Resnick MJ; Bergey MR; Sonnad SS; Tomaszewski J; VanArsdalen K; Malkowicz SB
    Urology; 2009 Jul; 74(1):161-5. PubMed ID: 19371932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP
    Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer.
    Dretler SP; Ragsdale BD; Leadbetter WF
    Trans Am Assoc Genitourin Surg; 1972; 64():79-84. PubMed ID: 4654526
    [No Abstract]   [Full Text] [Related]  

  • 17. Separate submission of standard lymphadenectomy in 6 packets versus en bloc lymphadenectomy in bladder cancer.
    Ather MH; Alam Z; Jamshaid A; Siddiqui KM; Sulaiman MN
    Urol J; 2008; 5(2):94-8. PubMed ID: 18592461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):137-49; discussion 149-51. PubMed ID: 16793197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.